Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.

International journal of molecular sciences - 29 Mar 2020

Fang Yi-Hsien, Wang Saprina P H, Gao Zi-Han, Wu Sheng-Nan, Chang Hsien-Yuan, Yang Pei-Jung, Liu Ping-Yen, Liu Yen-Wen

Abstract excerpt

Mature mammalian hearts possess very limited regenerative potential. The irreversible cardiomyocyte loss after heart injury can lead to heart failure and death. Pluripotent stem cells (PSCs) can differentiate into cardiomyocytes for cardiac repair, but there are obstacles to their clinical application. Among these obstacles is their potential for post-transplant rejection. Although human amniotic fluid-derived...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amniotic Fluid
Share to Electrophysiological Phenomena

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Embryonic Stem Cells

Share to Muscle Development

Share to Myocytes, Cardiac

Share to Regeneration

Share to Stem Cell Transplantation

Share to Ventricular Function, Left

Source

Open in PubMed Open full text

Identifiers

PMID: 32235313
DOI: 10.3390/ijms21072359
PMCID: PMC7177657

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.PMID 32235313Read ↗

Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart DiseaseSemantic proximity Read ↗

Human Amniotic Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells May Generate a Universal Source of Cardiac CellsSemantic proximity Read ↗

Derivation and High Engraftment of Patient-Specific Cardiomyocyte Sheet Using Induced Pluripotent Stem Cells Generated From Adult Cardiac FibroblastSemantic proximity Read ↗

MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy ModelSemantic proximity Read ↗

Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repairSemantic proximity Read ↗

Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.Semantic proximity Read ↗

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow CytometrySemantic proximity Read ↗

Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid CellsSemantic proximity Read ↗

Functional cardiomyocytes derived from human induced pluripotent stem cells.Semantic proximity Read ↗

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patientsSemantic proximity Read ↗

Deriving Cardiomyocytes from Human AmniocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.